HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Dr Robert Alexander Joins T3D Therapeutics’ Scientific Advisory Board
Alzheimer's disease expert Dr Robert Alexander will help shape the future development path of T3D Therapeutics' lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer's patients.
Doug Cassidy Appointed President of the Deep 6 AI Precision Research Ecosystem, the Largest Network of Sites and Sponsors Using AI To Accelerate Research
"Doug Cassidy, formerly our SVP and GM of healthcare organizations, has led the growth of our Ecosystem—from the first site, Cedars-Sinai in 2017, to the launch of our life sciences vertical in 2021, to now," said Wout Brusselaers, founder and CEO of Deep 6 AI. "With over 25 years of diversified experience exclusively in the healthcare IT and clinical research technology sectors, Cassidy is poised to take on an expanded role as president of the Deep 6 AI Precision Research Ecosystem to drive its continued growth and improve collaboration between sites and sponsors."
Nima Farzan: New CEO at Latigo Biotherapeutics
Nima Farzan brings more than two decades' leadership experience with a strong track record in fundraising and IPOs.
Dasyo Welcomes Medical Aesthetics Industry Icon Domenic Serafino (Dom) as Executive Chair
Domenic Serafino was part of the start-up executive team at Syneron Medical Corp acting as its President of North America and Executive Vice President - Syneron Medical Israel. He was instrumental in helping Syneron IPO in 2004, reaching a market cap of $1.3 billion less than 18 months from IPO.
Clément Vidal Is Appointed New CEO at eCential
Under Clément Vidal's leadership, eCential Robotics will continue to build a culture of excellence, enhance the company's product portfolio roadmap, develop its commercial activities in the US as well as partner internationally with implant manufacturers, tech companies and research labs to expand the range of Applications available on its unique Open eCential Platform.
Chris McHugh Joins Zeus as Senior Vice President of Integrated Supply Chain
Chris McHugh has been named Senior Vice President of Integrated Supply Chain at Zeus and will be responsible for end-to-end operations across the company’s global network of manufacturing facilities
LeAnn Boyd Joins Presenters at Women Leaders in Healthcare Conference
Selected by Modern Healthcare as one of its Women Leaders for 2024, LeAnn Boyd is among an elite group of influential women working to improve the patient experience while advancing the objectives of their own organizations.
Josh Smale Appointed VP of Global Clinical and Scientific Affairs at R3 Vascular
Commenting on the appointment of Mr. Josh Smale, Christopher M. Ownes, President and CEO of R3 Vascular said, “On behalf of the R3 management team, I am very pleased to welcome Josh Smale as Vice President of Global Clinical and Scientific Affairs. Josh has a proven track record and more than 20 years of relevant medical device experience specializing in clinical and regulatory affairs strategy, clinical evidence generation and dissemination, and physician education. Among other key clinical and scientific affairs programs, Josh will lead our clinical trial efforts, including our pivotal ELITE trial for our next generation Magnitude drug eluting bioresorbable scaffold. We look forward to his contributions as we work towards establishing R3 Vascular as the leader in the development and manufacturing of fully bioresorbable vascular scaffolds.”
Long-time Collaborators Botond Roska and José-Alain Sahel Win the Wolf Prize 2024 in the Field of Medicine
The Wolf Prize, considered one of the most prestigious international awards, recognizes outstanding achievements in various fields including medicine.
LIfT BioSciences Appoints Antonin (Tony) de Fougerolles as Chairman of its Board of Directors
Alex Blyth, Chief Executive Officer of LIfT BioSciences commented: “On behalf of LIfT’s Board of Directors, I am pleased to welcome Tony to the Company as Chairman. Tony has extremely relevant experience, having played a key role in successfully bringing three new drug modalities to the market, extensive experience in immuno-oncology, and has helped build several multi-billion-dollar companies from start-up stage. This wealth of experience will prove invaluable to LIfT as we prepare to move into clinical trials for our allogeneic first-in-class neutrophil-based immuno-cell therapy and other exciting pipeline developments.”
Recent News
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”